Huntingtin plays an essential role in the adult hippocampus

Jessica C Barron1, Laura J Dawson2, Samantha J Carew1

  • 1Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.

Neurobiology of Disease
|January 24, 2025
PubMed

Insights

Wild-type huntingtin (wtHTT) reduction in adult mouse brains causes severe hippocampal abnormalities and neuronal dysfunction. Despite temporary synapse recovery, long-term memory and behavior impairments persist, highlighting risks of non-selective therapies.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntingtin (HTT) lowering therapies are in clinical trials, but many non-selectively reduce both mutant and wild-type HTT (wtHTT).
  • The consequences of wtHTT reduction in the mature brain, particularly in the hippocampus, remain largely unknown.

Purpose of the Study:

  • To investigate the role of wtHTT in adult hippocampal pyramidal neurons.
  • To explore the implications of wtHTT loss in the mature brain.

Main Methods:

  • Injected CaMKII-promoted AAV-Cre into the hippocampus of adult HTT floxed mice.
  • Assessed hippocampal structure, gliosis, synaptic morphology, neuronal excitability, and long-term potentiation.

Main Results:

  • wtHTT depletion caused macroscopic hippocampal abnormalities, reactive gliosis, and reduced presynaptic terminals.
  • Synaptic changes included increased postsynaptic spine density and larger excitatory postsynaptic currents.
  • Neuronal excitability and NMDA receptor-dependent long-term potentiation were significantly diminished.
  • Synapse density normalized at 6-8 months, but morphological and behavioral deficits persisted.

Conclusions:

  • wtHTT is crucial for maintaining hippocampal structure and function in the mature brain.
  • Non-selective HTT reduction poses risks to the hippocampus, potentially leading to lasting cognitive impairments.
  • The hippocampus may be particularly vulnerable to adverse effects of non-selective HTT-lowering therapies.